Syndax Announces Participation at Two Upcoming Investor Conferences

Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in two upcoming virtual investor conferences:

Related Keywords

,Syndax Pharmaceuticals Inc ,Syndax Pharmaceuticals ,Inc ,Barclays Global Healthcare Conference ,Biopharmaceutical Company ,Cancer Therapies ,Investor Conferences ,இன்க் ,பார்க்லேஸ் உலகளாவிய சுகாதாரம் மாநாடு ,புற்றுநோய் சிகிச்சைகள் ,முதலீட்டாளர் மாநாடுகள் ,